When prostate cancer patients need therapy to reduce male hormone levels, delivering some of the treatment via a patch on the ...

A paper inadvertently published on the website of an ASCO conference revealed good results for mevrometostat in treating ...

The FDA approved Datroway to treat metastatic or unresectable HR+/HER2- breast cancer in people who have tried standard chemo ...

Dr. Debu Tripathy discusses the FDA approval of Enhertu in unresectable or metastatic hormone receptor HR+, HER2-low or -ultralow breast cancer.

Breast cancers at all stages are defined by the structure of their genomes, researchers find. Targeting these processes early is likely to offer unexpected therapeutic avenues.

Hormone therapy uses medication to lower or block ... These systems use nanoparticles to more effectively deliver cancer drugs. Some examples of cancer drugs that may use a nanoparticle-based ...

Drug in Clinical Trials for Breast Cancer ... Dec. 3, 2024 — Today, women with estrogen-sensitive breast cancer receive anti-hormonal therapy. Researchers now show that postmenopausal women ...

Findings showed datopotamab deruxtecan reduced the risk of disease progression or death by 37% compared with chemotherapy.

Breast cancers at all stages are defined by the structure of their genomes, Stanford Medicine researchers find. Targeting these processes early is likely to offer unexpected therapeutic avenues.

On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...

Chemotherapy for breast cancer may be more effective during specific stages of the menstrual cycle, according to data from ...